BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16413063)

  • 21. A chimeric TCR-beta chain confers increased susceptibility to EAE.
    Petersen TR; Lata R; Spittle E; Bäckström BT
    Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
    Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
    J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-2 promotes antigenic reactivity of rested T cells but prolongs the postactivational refractory phase of activated T cells.
    Norris MS; McConnell TJ; Mannie MD
    Cell Immunol; 2001 Jul; 211(1):51-60. PubMed ID: 11585388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
    Maña P; Fordham SA; Staykova MA; Correcha M; Silva D; Willenborg DO; Liñares D
    J Neuroimmunol; 2009 May; 210(1-2):13-21. PubMed ID: 19344958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive transfer of myelin basic protein-induced experimental autoimmune encephalomyelitis between SJL and B10.S mice: correlation of priming milieus with susceptibility and resistance phenotypes.
    Chen F; Shaw MK; Li J; Lisak RP; Tse HY
    J Neuroimmunol; 2006 Apr; 173(1-2):146-54. PubMed ID: 16480778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23.
    Constantinescu CS; Tani M; Ransohoff RM; Wysocka M; Hilliard B; Fujioka T; Murphy S; Tighe PJ; Das Sarma J; Trinchieri G; Rostami A
    J Neurochem; 2005 Oct; 95(2):331-40. PubMed ID: 16086689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
    Meiron M; Zohar Y; Anunu R; Wildbaum G; Karin N
    J Exp Med; 2008 Oct; 205(11):2643-55. PubMed ID: 18852294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis.
    Matejuk A; Hopke C; Dwyer J; Subramanian S; Jones RE; Bourdette DN; Vandenbark AA; Offner H
    J Neurosci Res; 2003 Sep; 73(5):667-78. PubMed ID: 12929134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
    Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
    Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
    Bill R; Döring A; Deutsch U; Engelhardt B
    J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire.
    McCue D; Ryan KR; Wraith DC; Anderton SM
    J Neuroimmunol; 2004 Nov; 156(1-2):96-106. PubMed ID: 15465600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
    Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
    J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
    Sutton C; Brereton C; Keogh B; Mills KH; Lavelle EC
    J Exp Med; 2006 Jul; 203(7):1685-91. PubMed ID: 16818675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of experimental autoimmune encephalomyelitis by administration of cells expressing antigenic peptide covalently linked to MHC class II.
    Weishaupt A; Kreiss M; Gold R; Herrmann T
    J Neuroimmunol; 2004 Jul; 152(1-2):11-9. PubMed ID: 15223233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
    J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis.
    Koehler NK; Roebbert M; Dehghani K; Ballmaier M; Claus P; von Hoersten S; Shing M; Odin P; Strehlau J; Heidenreich F
    J Neurosci Res; 2008 Feb; 86(2):392-402. PubMed ID: 17893914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
    Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
    Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.